Skip to main content
. 2024 Feb 19;15:1355817. doi: 10.3389/fneur.2024.1355817

Table 3.

Factors associated with priority rankings in MANCOVA analysis: overall effect*.

Factor Global survey F-value (df), p-value Global survey** F-value (df), p-value NARCOMS survey** F-value (df), p-value
Type of participant 6.57 (36), <0.0001
Region 2.25 (18), 0.002 2.60 (18), 0.0003
Gender 2.18 (36), <0.0001
Race 0.80 (36), 0.80
Age 17.3 (18), <0.0001 19.3 (18), <0.0001 12.2 (18), <0.0001
Education 2.50 (18), 0.0004
Income 2.92 (36), <0.0001
No. physical comorbidities 1.09 (54), 0.30
Anxiety 1.06 (18), 0.39
Depression 2.95 (18), <0.0001
Physical activity 2.95 (18), <0.0001
Smoking status 1.33 (18), 0.16
Alcohol intake 1.46 (36), 0.036
Disability status 1.43 (36), 0.048
Disease-modifying therapy use 2.30 (18), 0.0014

*MANCOVA provides evidence of overall effect, but not directionality. **Sample restricted to women with MS. Bold indicates statistical significance.